Arcturus Therapeutics Holdings (ARCT) Enterprise Value (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) posted Enterprise Value of -$211.4 million for Q1 2026, up 8.46% on a QoQ basis from -$230.9 million in Q4 2025, and up 17.25% year-over-year from -$180.3 million in Q1 2025.
Arcturus Therapeutics Holdings (ARCT) Enterprise Value (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings' Enterprise Value history runs 9 years deep, the most recent figure standing at -$211.4 million for Q1 2026.
- Quarterly Enterprise Value rose 17.25% year-over-year to -$211.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$211.4 million (up 17.25% YoY) and the FY2025 annual result came in at -$230.9 million, up 33.82% from the prior year.
- Enterprise Value was -$211.4 million for Q1 2026 at Arcturus Therapeutics Holdings, up from -$230.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$211.4 million in Q1 2026 and bottomed at -$391.9 million in Q4 2022.
- A 5-year average of -$295.7 million and a median of -$311.9 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 42.57% — and 2023, when it sank 31.24%.
- Arcturus Therapeutics Holdings' Enterprise Value stood at -$391.9 million in 2022, then gained by 11.45% to -$347.0 million in 2023, then declined by 0.55% to -$348.9 million in 2024, then jumped by 33.82% to -$230.9 million in 2025, then climbed by 8.46% to -$211.4 million in 2026.
- Business Quant data shows ARCT's Enterprise Value at -$211.4 million in Q1 2026, -$230.9 million in Q4 2025, and -$235.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - | -211.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -211.38 Mn |
| Dec 31, 2025 | -230.91 Mn |
| Sep 30, 2025 | -235.36 Mn |
| Jun 30, 2025 | -251.47 Mn |
| Mar 31, 2025 | -255.45 Mn |
| Dec 31, 2024 | -348.91 Mn |
| Sep 30, 2024 | -292.18 Mn |
| Jun 30, 2024 | -315.33 Mn |
| Mar 31, 2024 | -343.40 Mn |
| Dec 31, 2023 | -347.01 Mn |
| Sep 30, 2023 | -311.92 Mn |
| Jun 30, 2023 | -323.47 Mn |
| Mar 31, 2023 | -327.94 Mn |
| Dec 31, 2022 | -391.88 Mn |
| Sep 30, 2022 | -237.68 Mn |
| Jun 30, 2022 | -283.49 Mn |
| Mar 31, 2022 | -319.68 Mn |
| Dec 31, 2021 | -370.49 Mn |
| Sep 30, 2021 | -413.88 Mn |
| Jun 30, 2021 | -433.57 Mn |